Chinese guidelines on the clinical application of 5-aminolevulinic acid-based photodynamic therapy in dermatology (2021 edition).

5-Aminolevulinic acid ALA-PDT Clinical application Dermatology Guideline Photodynamic therapy

Journal

Photodiagnosis and photodynamic therapy
ISSN: 1873-1597
Titre abrégé: Photodiagnosis Photodyn Ther
Pays: Netherlands
ID NLM: 101226123

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 25 02 2021
revised: 12 04 2021
accepted: 07 05 2021
pubmed: 16 5 2021
medline: 16 9 2021
entrez: 15 5 2021
Statut: ppublish

Résumé

Photodynamic Therapy with 5-aminolevulinic acid (ALA-PDT) has been widely applied in the treatment of skin diseases in China. To further standardize, guide, and promote the clinical applications of ALA-PDT in dermatology, the Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology, Photomedicine Therapeutic Equipment Group of Committee on Skin Disease, and Cosmetic Dermatology of China Association of Medical Equipment invited relevant experts engaged in ALA-PDT to revise and update the first edition of "Clinical application of 5-aminolevulinic acid-based photodynamic therapy: an expert consensus statement" and establish a more current edition, to provide an updated reference for Chinese dermatologists in clinical practice. In the guideline, the expert group reached consensus opinions on ALA-PDT with regard to mechanisms of action, therapeutic protocol, clinical applications, adverse reactions and countermeasures, precautions, care, and evaluation of efficacy.

Identifiants

pubmed: 33991660
pii: S1572-1000(21)00167-8
doi: 10.1016/j.pdpdt.2021.102340
pii:
doi:

Substances chimiques

Photosensitizing Agents 0
Aminolevulinic Acid 88755TAZ87

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102340

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Lei Shi (L)

Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.

Hongwei Wang (H)

Department of Dermatology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.

Kun Chen (K)

Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Jiangsu, China.

Jia Yan (J)

Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.

Bo Yu (B)

Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.

Shengchun Wang (S)

Department of Dermatology, Xijing Hospital, Fourth Medical University, Xi'an, China.

Rui Yin (R)

Department of Dermatology, Southwest Hospital, Army Medical University, Chongqing, China.

Xiang Nong (X)

Department of Dermatology, First Affiliated Hospital of Kunming Medical University, Kunming, China.

Xianbiao Zou (X)

Department of Dermatology, South China Hospital, Health Science Center, Shenzhen University, Shenzhen, China.

Zhou Chen (Z)

Department of Dermatology, Peking University People's Hospital, Beijing, China.

Chengxin Li (C)

Department of Dermatology, First Medical Center of Chinese PLA General Hospital, Beijing, China.

Liuqing Chen (L)

Department of Dermatology, Wuhan NO.1 Hospital, Hubei, China.

Chunlei Zhang (C)

Department of Dermatology, Peking University Third Hospital, Beijing, China.

Furen Zhang (F)

Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.

Heyi Zheng (H)

Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Min Zheng (M)

Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Ping Tu (P)

Department of Dermatology and Venereology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.

Jinhua Xu (J)

Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.

Juan Tao (J)

Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China.

Xiaojing Kang (X)

Department of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.

Kang Zeng (K)

Department of Dermatology and Venereology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Yan Lu (Y)

Department of Dermatology, 1st Affiliated Hospital, Nanjing Medical University, Nanjing, China.

Nan Yu (N)

Department of Dermatology, General Hospital of Ningxia Medical University, Ningxia, China.

Xia Lei (X)

Department of Dermatology, Daping Hospital, Army Medical University (Army Medical Center of PLA), Chongqing, China.

Meng Pan (M)

Department of Dermatology, School of Medicine, Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China.

Qiang Ju (Q)

Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Heng Gu (H)

Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Jiangsu, China. Electronic address: guheng@aliyun.com.

Xiuli Wang (X)

Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: wangxiuli20150315@163.com.

Articles similaires

Humans Neoplasms Male Female Middle Aged
Humans Male Female Aged Middle Aged
Humans Retrospective Studies Male Critical Illness Female

Classifications MeSH